Challenges of Administering Pancrelipase in Pancreatitis Patients

J Am Coll Nutr. 2016 May-Jun;35(4):334-8. doi: 10.1080/07315724.2015.1052592. Epub 2015 Dec 28.

Abstract

Objective: This study evaluated nutrition status to determine the impact of a novel approach using elemental nutrition compared to pancrelipase administration in patients with pancreatitis.

Methods: This retrospective study included adult patients with pancreatitis who were nil per os (NPO) and received elemental nutrition from August 2008 to 2010 (n = 24) or pancrelipase enzyme supplementation (PES) plus nonelemental enteral nutrition from August 2011 to 2013 (n = 41) at a large academic medical center. The primary outcome is the percentage of diarrhea-free days. Secondary outcomes include time-to-goal enteral nutrition from the enteral nutrition initiation and pre-albumin and albumin changes pre- and postenteral nutrition.

Results: There were no statistically significant differences between the 2 groups in percentage of diarrhea-free days (46.80% ± 29.03% vs 53.45% ± 36.76%, p = 0.45). Additionally, there were no differences in secondary outcomes of time-to-goal enteral nutrition and pre-albumin and albumin changes pre- and postenteral nutrition.

Conclusion: Utilizing elemental nutrition compared to PES plus nonelemental enteral nutrition in patients with pancreatitis was not associated with a significant reduction in percentage of diarrhea-free days, time-to-goal enteral nutrition, and nutrition status. A multicenter, prospective, randomized, controlled trial is warranted to further evaluate the efficacy of elemental nutrition in patients with pancreatitis.

Keywords: Preventative Nutrition and Chronic Disease; diets; metabolism; nutriceuticals; supplements and functional foods.

MeSH terms

  • Adult
  • Aged
  • Diarrhea / etiology
  • Diarrhea / prevention & control
  • Enteral Nutrition
  • Female
  • Food, Formulated
  • Humans
  • Male
  • Middle Aged
  • Pancreatitis / complications
  • Pancreatitis / drug therapy
  • Pancreatitis / therapy*
  • Pancrelipase / administration & dosage*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Pancrelipase